Figure 3From: A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects Mean (standard deviation) fecal content of sodium and potassium following CLP treatment and untreated control. Values are daily averages from Days 5-9, the time period reflective of steady state CLP exposure.Back to article page